Raymond James & Associates Amgen Inc Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Amgen Inc stock. As of the latest transaction made, Raymond James & Associates holds 989,504 shares of AMGN stock, worth $287 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

989,504

Previous 1,065,005 7.09%

Holding current value

$287 Million

Previous $333 Million 4.19%

% of portfolio

0.2%

Previous 0.22%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$309.38 - $337.38 $23.4 Million - $25.5 Million	-75,501 Reduced 7.09%	989,504 $319 Million
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $3.82 Million - $4.64 Million	-14,531 Reduced 1.35%	1,065,005 $333 Million
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $20.1 Million - $24.2 Million	-74,674 Reduced 6.47%	1,079,536 $307 Million
Q4 2023 Jan 16, 2024	SELL	$255.7 - $288.46 $5.54 Million - $6.25 Million	-21,680 Reduced 1.84%	1,154,210 $332 Million
Q3 2023 Oct 24, 2023	BUY	$218.65 - $271.46 $30.3 Million - $37.6 Million	138,678 Added 13.37%	1,175,890 $316 Million
Q2 2023 Jul 25, 2023	BUY	$214.27 - $253.37 $25.7 Million - $30.4 Million	119,813 Added 13.06%	1,037,212 $230 Million
Q1 2023 Apr 14, 2023	BUY	$225.79 - $275.2 $25.5 Million - $31.1 Million	112,931 Added 14.04%	917,399 $222 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $26.5 Million - $33.7 Million	-115,701 Reduced 12.57%	804,468 $211 Million
Q3 2022 Oct 25, 2022	BUY	$224.46 - $253.15 $22.1 Million - $24.9 Million	98,386 Added 11.97%	920,169 $207 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $2.16 Million - $2.41 Million	-9,379 Reduced 1.13%	821,783 $200 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $1.96 Million - $2.16 Million	-8,925 Reduced 1.06%	831,162 $201 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $424,608 - $485,926	2,135 Added 0.25%	840,087 $189 Million
Q3 2021 Nov 02, 2021	SELL	$212.27 - $248.7 $11.1 Million - $13 Million	-52,072 Reduced 5.85%	837,952 $178 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $166 Million - $184 Million	-710,827 Reduced 44.4%	890,024 $217 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $5.56 Million - $6.48 Million	25,045 Added 1.59%	1,600,851 $398 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $36.3 Million - $43.3 Million	-167,937 Reduced 9.63%	1,575,806 $362 Million
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $28.5 Million - $31.7 Million	121,463 Added 7.49%	1,743,743 $443 Million
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $128 Million - $157 Million	647,843 Added 66.48%	1,622,280 $383 Million
Q1 2020 Apr 21, 2020	BUY	$182.24 - $241.7 $18 Million - $23.9 Million	98,686 Added 11.27%	974,437 $198 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $16.4 Million - $21.1 Million	86,790 Added 11.0%	875,751 $211 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $126,229 - $151,249	-725 Reduced 0.09%	788,961 $153 Million
Q2 2019 Aug 06, 2019	BUY	$166.7 - $195.41 $6.01 Million - $7.04 Million	36,033 Added 4.78%	789,686 $146 Million
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $1.94 Million - $2.19 Million	-10,745 Reduced 1.41%	753,653 $143 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $10.5 Million - $12.3 Million	58,906 Added 8.35%	764,398 $149 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $5.8 Million - $6.54 Million	-31,321 Reduced 4.25%	705,492 $146 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $5.13 Million - $5.76 Million	30,905 Added 4.38%	736,813 $136 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $9.46 Million - $11 Million	55,806 Added 8.58%	705,908 $120 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $3.53 Million - $3.94 Million	20,910 Added 3.32%	650,102 $113 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $2.95 Million - $3.37 Million	17,619 Added 2.88%	629,192 $117 Million
Q2 2017 Aug 14, 2017	BUY	N/A	611,573	611,573 $105 Million

Others Institutions Holding AMGN

# of Institutions

3,278

Shares Held

442M

Call Options Held

6.15M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Amgen Inc Transaction History